A leader from the behavioral science specialist shares ways to use precision engagement and other methods to increase patient adherence in clinical studies.
The University of Birmingham has developed a cell-penetrating peptide it claims could be used to make eye drop versions of age-related macular degeneration drugs currently delivered by injection.
Regulatory enforcement saw fewer counterfeit drug websites in 2014 but sellers are turning to YouTube and social media sites to advertise their products, according to the MHRA.
Chemists at MIT have created a triple warhead against cancer. They believe theirs is the first example a polymer nanoparticle which carries a precise ratio of three drugs that can be released in response to three distinct triggers.
The counterfeiting of over-the-counter drugs is a growing problem according to an ex-criminal prosecutor, but the nature of such medicines means the problem often goes unreported.
Pharma industry employees and wholesalers with access to narcotic APIs would be subject to background checks and drug testing under new proposals being considered in the US.
The US House on Saturday passed legislation that calls for the tracking and tracing of pharmaceuticals through the nation's supply chain after agreeing on the bill with the Senate last week.
Improving safety and efficacy coupled with drug industry desire for “stronger” patents will drive growth of the biologics sector over the next five years, according to new research.
Counterfeit drugs worth €10.5bn ($14.3bn) are sold in Europe each year with Germans and Italians being the biggest consumers of such products, according to new Pfizer sponsored research.
A 20ft container of counterfeit pharmaceuticals has been impounded
by the Nigerian National Agency for Food and Drug Administration
and Control (NAFDAC).
The importance of paediatric drug formulations and clinical trials
in children was highlighted at this month's American Association of
Pharmaceutical Scientists (AAPS) conference in San Diego.
A new Belgian company has joined the throng of pharmas tapping into
the booming drug delivery business, but claims that its unique
technologies will carve it a place as one of the industry's key
players.
Reformulations of pseudoephedrine- and ephedrine-containing drugs
in the UK look unlikely following the announcement of less extreme
restrictions on the sale of the pharmaceuticals.
New research has branded pharmaceutical manufacturers in India as
being responsible for the release of substantial and worrying
amounts of active pharmaceutical ingredients (APIs) into the
environment.
Irish researchers have developed a technique that could be used to
deliver controlled amounts of drugs to diseased tissues while
minimising side effects simply by shining light on the target.
Amgen will strengthen its drug portfolio aimed at fighting renal
disease after agreeing to acquire Ilypsa, a private biotechnology
company which is developing a novel drug for the treatment of
elevated blood phosphate (hyperphosphataemia)...
Over 50 per cent of proteins in the body are considered too
difficult to target with drugs; they are 'undruggable'. Yet it is
exactly these molecules US pharma firm Avalon is focussing on.
A new machine developed by US firm Vardex Laser promises to offer a
unique solution to the global problem of drug counterfeiting,
protecting products right down to the pill itself.
Proposed legislation to allow cheap drug imports into the US met
with opposition this week as representatives from the
pharmaceutical industry resisted the move saying there are
'better, safer alternatives' to imported drugs.
A new partnership between India's Reliance Life Sciences (RLS) and
Ireland's GeneMedix will provide new contract opportunities for
European contract bio-manufacturers.
A tool that predicts which experimental drugs will ultimately be
approved for release could cut development costs by nearly 40 per
cent, saving pharma companies hundreds of millions per new drug.
A US government report has warned that the pharmaceutical industry
is not producing enough new drugs despite spending more on research
and development.
Researchers have discovered that using nanotechnology could help
reduce fatalities from drug overdoses, as nanoparticles can act as
potential antidotes.
Pfizer has issued another recall for packs of its blockbuster
cholesterol drug Lipitor after UK regulators found evidence of more
counterfeit product in the legitimate supply chain from a batch
whose withdrawal was supposed to have...
A new laboratory test that identifies patients who benefit most
from targeted cancer drugs was the talk of the annual meeting of
the American Society of Clinical Oncology (ASCO) as the test's
accuracy is sure to save hundreds...
While praising the benefits of radio-frequency identification
(RFID), the US Food and Drug Administration (FDA) has refrained
from demanding its implementation in new measures it unveiled to
combat counterfeit drugs, asking instead...
The US Food and Drug Administration (FDA) has linked its
Counterfeit Alert Network (CAN) to SafeMeds Alert System, an
electronic mailing list backed by pharmaceutical manufacturers that
sends warnings about fake drugs to anyone who...
Bruker Optics have reached an agreement with the Chinese State Food
and Drug Administration (SFDA), which sees Bruker technology
integrated into regional Food and Drug Administration offices
aiding the fight against illegal counterfeit...
Australian company pSivida has completed its acquisition of US drug
delivery firm, Control Delivery Systems (CDS), as part of its
strategy to expand its presence in the US biotech industry.
A US think tank, The Centre for Medicines in the Public Interest,
has released a new report projecting counterfeit drug sales to
reach $75 billion in 2010, a 92 per cent increase from 2005.
Scientists have discovered the antimonial drugs used to treat
Leishmaniasis focus on the same drug targets as those drugs used to
treat sleeping sickness and Chagas disease, raising the possibility
of a multi-functional drug that...
The cost and time required to develop a new drug and bring it to
market is determined by the therapeutic category of that drug. The
results are consistent with the model that predicts R&D efforts
are generally shifting toward...
In response to growing concerns about counterfeit drugs in the US
drug supply, an industry group has submitted a report to the Food
and Drug Administration (FDA) as a commentary on policy issues
surrounding prescription drug counterfeiting,...
The US authorities have arrested another individual for suspected
involvement in the distribution of fake copies of Pfizer's
blockbuster cholesterol-lowering drug Lipitor (atorvastatin).
CIMA is granted a US patent covering the use of effervescence to
improve the absorption of poorly-soluble drugs and target delivery
to specific areas of the GI tract.
